EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery

Santosh Gupta iD, Lyubomyr Lytvynchuk, Taras Ardan, Hana Studenovska, Ruchi Sharma, Georgina Faura, Lars Eide, Rama Shanker Verma, Ljubo Znaor, Slaven Erceg iD, Knut Stieger, Jan Motlik und 2 weitere

Stem Cells Translational Medicine · 2023

DOI: 10.1093/stcltm/szad039 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, 2023. Verfasst von Santosh Gupta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute for Clinical Medicine, Faculty of Medicine, University of …. Hauptthemen laut MEDLINE: Macular Degeneration, Pluripotent Stem Cells. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marie Curie, Czech Science Foundation, Norway Grants and Technology Agency of the Czech Republic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal pigment epithelium (RPE) is a critical cell monolayer forming the blood-retina-barrier (BRB) and a permeable bridge between the choriocapillaris and the retina. RPE is also crucial in maintaining photoreceptor function and for completing the visual cycle. Loss of the RPE is associated with the development of degenerative diseases like age-related macular degeneration (AMD). To treat diseases like AMD, pluripotent stem cell-derived RPE (pRPE) has been recently explored extensively as a regenerative module. pRPE like other ectodermal tissues requires specific lineage differentiation and long-term in vitro culturing for maturation. Therefore, understanding the differentiation process of RPE could be useful for stem cell-based RPE derivation. Developing pRPE-based transplants and delivering them into the subretinal space is another aspect that has garnered interest in the last decade. In this review, we discuss the basic strategies currently employed for stem cell-based RPE derivation, their delivery, and recent clinical studies related to pRPE transplantation in patients. We have also discussed a few limitations with in vitro RPE culture and potential solutions to overcome such problems which can be helpful in developing functional RPE tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular DegenerationPluripotent Stem CellsHumansRetinal Pigment EpitheliumRetinaCell Differentiation

Stichwörter der Autor:innen

cell deliverydifferentiationembryonic stem cellsinduced pluripotent stem cellsretinal pigment epithelium

Autor:innen und Institutionen

  • Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Department of Ophthalmology, Justus Liebig University Giessen, University Hospital Giessen and Marburg GmbH, Giessen, Germany.
  • Department of Ophthalmology, Karl Landsteiner Institute for Retinal Research and Imaging, Vienna, Austria.
  • Laboratory of Cell Regeneration and Cell Plasticity, Institute of Animal Physiology and Genetics, Academy of Sciences of the Czech Republic, Libechov, Czech Republic.
  • Department of Biomaterials and Bioanalogous Systems, Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
  • Ocular and Stem Cell Translational Research, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

ORCID-Profile: Santosh Gupta, Slaven Erceg

Förderung

  • Marie Curie
  • Czech Science Foundation
  • Norway Grants and Technology Agency of the Czech Republic
  • IAPG institutional

Zitieren

APA

Gupta, S., Lytvynchuk, L., Ardan, T., Studenovska, H., Sharma, R., Faura, G., Eide, L., Shanker Verma, R., Znaor, L., Erceg, S., Stieger, K., Motlik, J., Petrovski, G., & Bharti, K. (2023). Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szad039

Vancouver

Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Sharma R, Faura G, et al. Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery. Stem Cells Translational Medicine. 2023. doi:10.1093/stcltm/szad039

BibTeX
@article{Gupta2023,
  author = {Gupta, Santosh and Lytvynchuk, Lyubomyr and Ardan, Taras and Studenovska, Hana and Sharma, Ruchi and Faura, Georgina and Eide, Lars and Shanker Verma, Rama and Znaor, Ljubo and Erceg, Slaven and Stieger, Knut and Motlik, Jan and Petrovski, Goran and Bharti, Kapil},
  title = {Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery},
  journal = {Stem Cells Translational Medicine},
  year = {2023},
  doi = {10.1093/stcltm/szad039}
}
Kostenlos starten →